Zevra Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Zevra Therapeutics, Inc. (ZVRA) reported Basic Shares Outstanding (Weighted Average) of 59.16 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- Zevra Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 59.16M shares, a 7.99% increase year-over-year.
- Zevra Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 58.41M shares, a 7.97% increase year-over-year.
- Zevra Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 56.40M shares, a 5.47% increase year-over-year.
- Zevra Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 55.95M shares, a 17.03% increase year-over-year.
- Zevra Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 55.31M shares, a 19.59% increase from fiscal 2024.
- Zevra Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 46.25M shares, a 30.46% increase from fiscal 2023.
- Zevra Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 35.45M shares, a 2.79% increase from fiscal 2022.
- Zevra Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 34.49M shares, a 15.87% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 59.16M shares 10-Q · filed 2026-08-05 | 58.78M shares 10-Q · filed 2026-08-05 | 57.99M shares derived: average of 3 quarters · filed 2026-08-05 | 57.48M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | 58.41M shares 10-Q · filed 2026-05-06 | 57.40M shares derived: average of 2 quarters · filed 2026-05-06 | 56.92M shares derived: average of 3 quarters · filed 2026-05-06 | 56.38M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | 56.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 56.17M shares derived: average of 2 quarters · filed 2026-03-09 | 55.71M shares derived: average of 3 quarters · filed 2026-08-05 | 55.31M shares 10-K · filed 2026-03-09 | |||
| 2025-09-30 | 55.95M shares 10-Q · filed 2025-11-05 | 55.37M shares derived: average of 2 quarters · filed 2026-08-05 | 54.95M shares 10-Q · filed 2025-11-05 | 54.58M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | 54.78M shares 10-Q · filed 2026-08-05 | 54.44M shares 10-Q · filed 2026-08-05 | 54.12M shares derived: average of 3 quarters · filed 2026-08-05 | 52.54M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | 54.10M shares 10-Q · filed 2026-05-06 | 53.78M shares derived: average of 2 quarters · filed 2026-05-06 | 51.79M shares derived: average of 3 quarters · filed 2026-05-06 | 49.32M shares derived: average of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | 53.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 50.64M shares derived: average of 2 quarters · filed 2026-03-09 | 47.73M shares derived: average of 3 quarters · filed 2026-03-09 | 46.25M shares 10-K · filed 2026-03-09 | |||
| 2024-09-30 | 47.81M shares 10-Q · filed 2025-11-05 | 44.85M shares derived: average of 2 quarters · filed 2025-11-05 | 43.84M shares 10-Q · filed 2025-11-05 | 42.55M shares derived: average of 4 quarters · filed 2025-11-05 | |||
| 2024-06-30 | 41.90M shares 10-Q · filed 2025-08-12 | 41.84M shares 10-Q · filed 2025-08-12 | 40.80M shares derived: average of 3 quarters · filed 2025-08-12 | 39.28M shares derived: average of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | 41.78M shares 10-Q · filed 2025-05-13 | 40.25M shares derived: average of 2 quarters · filed 2025-05-13 | 38.41M shares derived: average of 3 quarters · filed 2025-05-13 | 37.28M shares derived: average of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | 38.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | 36.72M shares derived: average of 2 quarters · filed 2025-03-12 | 35.78M shares derived: average of 3 quarters · filed 2025-03-12 | 35.45M shares 10-K · filed 2025-03-12 | |||
| 2023-09-30 | 34.72M shares 10-Q · filed 2024-11-13 | 34.31M shares derived: average of 2 quarters · filed 2024-11-13 | 34.36M shares 10-Q · filed 2024-11-13 | 34.40M shares derived: average of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | 33.90M shares 10-Q · filed 2024-08-14 | 34.18M shares 10-Q · filed 2024-08-14 | 34.29M shares derived: average of 3 quarters · filed 2024-08-14 | 34.34M shares derived: average of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | 34.47M shares 10-Q · filed 2024-05-09 | 34.49M shares derived: average of 2 quarters · filed 2024-05-09 | 34.49M shares derived: average of 3 quarters · filed 2024-05-09 | 34.48M shares derived: average of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | 34.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 34.50M shares derived: average of 2 quarters · filed 2024-04-01 | 34.48M shares derived: average of 3 quarters · filed 2024-04-01 | 34.49M shares 10-K · filed 2024-04-01 | |||
| 2022-09-30 | 34.49M shares 10-Q · filed 2023-11-07 | 34.47M shares derived: average of 2 quarters · filed 2023-11-07 | 34.48M shares 10-Q · filed 2023-11-07 | 34.70M shares derived: average of 4 quarters · filed 2023-11-07 | |||
| 2022-06-30 | 34.45M shares 10-Q · filed 2023-08-14 | 34.48M shares 10-Q · filed 2023-08-14 | 34.77M shares derived: average of 3 quarters · filed 2023-08-14 | 34.88M shares derived: average of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | 34.51M shares 10-Q · filed 2023-05-15 | 34.93M shares derived: average of 2 quarters · filed 2023-05-15 | 35.03M shares derived: average of 3 quarters · filed 2023-05-15 | 33.56M shares derived: average of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | 35.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 35.28M shares derived: average of 2 quarters · filed 2023-03-07 | 33.25M shares derived: average of 3 quarters · filed 2023-03-07 | 29.77M shares 10-K · filed 2023-03-07 | |||
| 2021-09-30 | 35.22M shares 10-Q · filed 2022-11-10 | 32.20M shares derived: average of 2 quarters · filed 2022-11-10 | 27.90M shares 10-Q · filed 2022-11-10 | 22.02M shares derived: average of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | 29.17M shares 10-Q · filed 2022-08-12 | 24.19M shares 10-Q · filed 2022-08-12 | 17.62M shares derived: average of 3 quarters · filed 2022-08-12 | 14.32M shares derived: average of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | 19.15M shares 10-Q · filed 2022-05-12 | 11.84M shares derived: average of 2 quarters · filed 2022-05-12 | 9.37M shares derived: average of 3 quarters · filed 2022-05-12 | 8.01M shares derived: average of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | 4.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 4.48M shares derived: average of 2 quarters · filed 2022-03-31 | 4.30M shares derived: average of 3 quarters · filed 2022-03-31 | 3.98M shares 10-K · filed 2022-03-31 | |||
| 2020-09-30 | 4.43M shares 10-Q · filed 2021-11-10 | 70.81M shares 10-Q · filed 2020-10-30 | 4.19M shares derived: average of 2 quarters · filed 2021-11-10 | 3.79M shares 10-Q · filed 2021-11-10 | 60.72M shares 10-Q · filed 2020-10-30 | ||
| 2020-06-30 | 3.95M shares 10-Q · filed 2021-08-13 | 63.16M shares 10-Q · filed 2020-08-12 | 3.48M shares 10-Q · filed 2021-08-13 | 55.62M shares 10-Q · filed 2020-08-12 | |||
| 2019-09-30 | 30.13M shares 10-Q · filed 2020-10-30 | 29.26M shares derived: average of 2 quarters · filed 2020-10-30 | 28.42M shares 10-Q · filed 2020-10-30 | ||||
| 2019-06-30 | 28.39M shares 10-Q · filed 2020-08-12 | 27.55M shares 10-Q · filed 2020-08-12 | |||||
| 2018-09-30 | 16.03M shares 10-Q · filed 2019-11-14 | 15.68M shares derived: average of 2 quarters · filed 2019-11-14 | 15.39M shares 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | 15.32M shares 10-Q · filed 2019-08-13 | 15.06M shares 10-Q · filed 2019-08-13 | |||||
| 2017-06-30 | 14.65M shares 10-Q · filed 2018-08-10 | 14.65M shares 10-Q · filed 2018-08-10 | |||||
| 2016-06-30 | 14.60M shares 10-Q · filed 2017-08-10 | 14.55M shares 10-Q · filed 2017-08-10 | |||||
| 2015-06-30 | 12.16M shares 10-Q · filed 2016-08-11 | 7.27M shares 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |